JW Pharma rolls out new intravenous iron preparation

Published: 2011-04-04 06:59:00

Updated: 2011-04-04 06:59:00

JW Pharma said Thursday it has launched Ferinject Inj. (ferric carboxymaltose) that may offer convenient administration and permit high doses of iron to be given in a short period.

The chemical characteristic of the iron-carbohyrate complex means that iron is released slowly, avoiding toxicity...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK